166 related articles for article (PubMed ID: 24803829)
1. Association between esophageal cancer risk and EPHX1 polymorphisms: a meta-analysis.
Li QT; Kang W; Wang M; Yang J; Zuo Y; Zhang W; Su DK
World J Gastroenterol; 2014 May; 20(17):5124-30. PubMed ID: 24803829
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between EPHX1 polymorphism and esophageal cancer risk: evidence from meta-analysis.
Yan YL; Chen X; Liang HJ; Wang J; Li TJ; Li RL; Li S; Qin X
Dis Esophagus; 2015; 28(2):164-71. PubMed ID: 25714851
[TBL] [Abstract][Full Text] [Related]
3. Association between microsomal epoxide hydrolase 1 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.
Zhao W; Luo J; Cai X
Tumour Biol; 2013 Aug; 34(4):2383-8. PubMed ID: 23681797
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
[TBL] [Abstract][Full Text] [Related]
5. EPHX1 Tyr113His and His139Arg polymorphisms in esophageal cancer risk: a meta-analysis.
Tan X; He WW; Wang YY; Shi LJ; Chen MW
Genet Mol Res; 2014 Jan; 13(1):649-59. PubMed ID: 24615030
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and the Risk of Head and Neck Cancer.
Chen H; Ge L; Sui Q; Lin M
PLoS One; 2015; 10(4):e0123347. PubMed ID: 25923690
[TBL] [Abstract][Full Text] [Related]
7. Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India.
Ihsan R; Chattopadhyay I; Phukan R; Mishra AK; Purkayastha J; Sharma J; Zomawia E; Verma Y; Mahanta J; Saxena S; Kapur S
J Gastroenterol Hepatol; 2010 Aug; 25(8):1456-62. PubMed ID: 20659238
[TBL] [Abstract][Full Text] [Related]
8. EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.
Dura P; Bregitha CV; Te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
Oncol Rep; 2012 Jun; 27(6):1710-6. PubMed ID: 22447130
[TBL] [Abstract][Full Text] [Related]
9. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer.
Jain M; Tilak AR; Upadhyay R; Kumar A; Mittal B
Toxicol Appl Pharmacol; 2008 Jul; 230(2):247-51. PubMed ID: 18406439
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis demonstrates lack of an association of microsomal epoxide hydrolase 1 polymorphisms with esophageal cancer risk.
Hu JJ; Wang ZT; Li B
Genet Mol Res; 2013 Oct; 12(4):4540-8. PubMed ID: 24222229
[TBL] [Abstract][Full Text] [Related]
11. System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.
Zhao ZQ; Guan QK; Yang FY; Zhao P; Zhou B; Chen ZJ
Tumour Biol; 2012 Apr; 33(2):523-35. PubMed ID: 22161138
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.
Yang X; Wang Y; Wang G
J Exp Clin Cancer Res; 2014 Sep; 33(1):82. PubMed ID: 25261893
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in the
Walia HK; Singh N; Sharma S
Future Oncol; 2021 Dec; 17(35):4925-4946. PubMed ID: 34672683
[TBL] [Abstract][Full Text] [Related]
14. Impact of epoxide hydrolase 1 polymorphisms on lung cancer susceptibility in Asian populations.
Yu W; Lin Z; Qu B
Cell Biochem Biophys; 2015 Mar; 71(2):813-20. PubMed ID: 25312477
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and the risk of breast carcinoma.
Zhong JH; Li LQ; Mo XS; Gong WF; Ma L; Chen J; You XM
Genet Mol Res; 2015 Apr; 14(2):4133-41. PubMed ID: 25966185
[TBL] [Abstract][Full Text] [Related]
16. Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China.
Zhang JH; Jin X; Li Y; Wang R; Guo W; Wang N; Wen DG; Chen ZF; Kuang G; Wei LZ; Wang SJ
World J Gastroenterol; 2003 Dec; 9(12):2654-7. PubMed ID: 14669306
[TBL] [Abstract][Full Text] [Related]
17. Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia.
Tumer TB; Sahin G; Arinç E
Arch Toxicol; 2012 Mar; 86(3):431-9. PubMed ID: 21983886
[TBL] [Abstract][Full Text] [Related]
18. Try113His and His139Arg polymorphisms in the microsomal epoxide hydrolase gene are not associated with risk of breast cancer.
Gong WF; He W; Zhang QM; Xiang BD; Ma L; Huang S; Bai T; Zhong JH; Li LQ
Tumour Biol; 2014 Aug; 35(8):8087-93. PubMed ID: 24840637
[TBL] [Abstract][Full Text] [Related]
19. Association of Activity Altering Genotypes - Tyr113His and His139Arg in Microsomal Epoxide Hydrolase Enzyme with Esophageal Squamous Cell Carcinoma.
Nabi S; Bhat GA; Iqbal B; Lone MM; Lone GN; Khan MA; Dar NA
Nutr Cancer; 2019; 71(5):806-817. PubMed ID: 30633570
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]